Skip to content

Efficacy of Arjuna ghana vati and Sarpagandha ghana vati in Hypertension

A simple randomized comparative study to evaluate the efficacy of Arjuna ghana vati and Sarpagandha ghana vati in Hypertension ~ Vyana bala vaishamyam

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043858
Enrollment
60
Registered
2022-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Chaudhary Brahm Prakash Ayurved Charak Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with Stage 1 Hypertension according to JNC 8th Criteria 2.Patients presenting with symptoms of hypertension and comes under pre hypertension 3.Patients freshly diagnosed with hypertension 4.Patients who have been already diagnosed with hypertension and are not under regular medications for minimum of two months and comes under stage 1 hypertension 5.Patients with isolated systolic hypertension and Essential hypertension

Exclusion criteria

Exclusion criteria: 1.Patients below 18 years of age and above 60 years of age 2.Patient not willing for trial 3.Patients having systolic blood pressure greater than 160 mm hg and diastolic blood pressure greater than 100 mm hg 4.Complicated hypertensive cases like Nephropathy and left ventricular hypertrophy, Heart block congestive heart failure, coronary artery disease and retinopathy 5.Patients suffering with Diabetes mellitus 6.Patients with isolated diastolic hypertension, Accelerated and malignant hypertension 7.Patient taking steroids, oral contraceptive pills. estrogen replacement therapy or NSAID group of drugs 8.Patient with severe other illness hepatic or renal failure 9.Secondary hypertension

Design outcomes

Primary

MeasureTime frame
Improvement in the Systolic blood pressure, Diastolic blood pressure, Mean arterial PressureTimepoint: 0th,1st, 15th, 30th and 45th day of trial

Secondary

MeasureTime frame
Improvement in the Lipid profiles (Total cholesterol, Triglycerides, High Density Lipoproteins, Low density Lipoproteins), two weeks sleep diary - intermittent awakenings in sleep, sleep duration, day time drowsiness, Subjective improvement in symptomsTimepoint: 0th day and 30th day of trial

Countries

India

Contacts

Public ContactDr Manohari P

Ch Brahm Prakash Ayurved Charak Sansthan

abdratal8@gmail.com9958046550

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026